glp-1 cigna coverage is ending employee for weight-loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Cigna limits employer spending on

Join our commenting forum Join thought-provoking conversations, follow other Independent readers and see their replies Comments

* For those taking Wegovy pill, 76% achieved 5% or greater body weight loss (from a baseline body weight of 235 lb) versus 31% taking placebo (from a baseline body weight of 231 lb.)

V souasn dob dodv sv doplky stravy do 120 zem svta

Rosario et al., 2021)

You still have to nourish your body with enough fuel and the right fuels to perform." Shannon Christen, Registered Dietitian, UCHealth Success with GLP-1 medications often calls for expert guidance

It can not only help improve the skins health and brightness, but also reduce the dullness and make sure your skin looks youthful